Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis

Phase 3 Completed 50 enrolled University Health Network, Toronto

RandomizedSingle-groupDouble-blindTreatment

Summary

This study is a double-blind, placebo-controlled, randomized clinical trial to determine whether IVIG is effective in improving motor scores in patients with myasthenia gravis and worsening weakness.

Timeline

Start: 2004-03
Primary completion: —
Completion: 2005-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Immune Globulin Intravenous (Human)	Protein / enzyme biologic	—	Intravenous

Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis

Summary

Timeline

Drugs

Indications